199 related articles for article (PubMed ID: 27353365)
1. The ER structural protein Rtn4A stabilizes and enhances signaling through the receptor tyrosine kinase ErbB3.
Hatakeyama J; Wald JH; Rafidi H; Cuevas A; Sweeney C; Carraway KL
Sci Signal; 2016 Jun; 9(434):ra65. PubMed ID: 27353365
[TBL] [Abstract][Full Text] [Related]
2. Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth.
Yen L; Cao Z; Wu X; Ingalla ER; Baron C; Young LJ; Gregg JP; Cardiff RD; Borowsky AD; Sweeney C; Carraway KL
Cancer Res; 2006 Dec; 66(23):11279-86. PubMed ID: 17145873
[TBL] [Abstract][Full Text] [Related]
3. Quantity control of the ErbB3 receptor tyrosine kinase at the endoplasmic reticulum.
Fry WH; Simion C; Sweeney C; Carraway KL
Mol Cell Biol; 2011 Jul; 31(14):3009-18. PubMed ID: 21576364
[TBL] [Abstract][Full Text] [Related]
4. Neuregulin-induced ErbB3 downregulation is mediated by a protein stability cascade involving the E3 ubiquitin ligase Nrdp1.
Cao Z; Wu X; Yen L; Sweeney C; Carraway KL
Mol Cell Biol; 2007 Mar; 27(6):2180-8. PubMed ID: 17210635
[TBL] [Abstract][Full Text] [Related]
5. Oligomerization of the Nrdp1 E3 ubiquitin ligase is necessary for efficient autoubiquitination but not ErbB3 ubiquitination.
Printsev I; Yen L; Sweeney C; Carraway KL
J Biol Chem; 2014 Mar; 289(12):8570-8. PubMed ID: 24519943
[TBL] [Abstract][Full Text] [Related]
6. An RBCC protein implicated in maintenance of steady-state neuregulin receptor levels.
Diamonti AJ; Guy PM; Ivanof C; Wong K; Sweeney C; Carraway KL
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2866-71. PubMed ID: 11867753
[TBL] [Abstract][Full Text] [Related]
7. Post-transcriptional mechanisms contribute to the suppression of the ErbB3 negative regulator protein Nrdp1 in mammary tumors.
Ingalla EQ; Miller JK; Wald JH; Workman HC; Kaur RP; Yen L; Fry WH; Borowsky AD; Young LJ; Sweeney C; Carraway KL
J Biol Chem; 2010 Sep; 285(37):28691-7. PubMed ID: 20628057
[TBL] [Abstract][Full Text] [Related]
8. Nrdp1-mediated ErbB3 degradation inhibits glioma cell migration and invasion by reducing cytoplasmic localization of p27(Kip1).
Shi H; Gong H; Cao K; Zou S; Zhu B; Bao H; Wu Y; Gao Y; Tang Y; Yu R
J Neurooncol; 2015 Sep; 124(3):357-64. PubMed ID: 26088461
[TBL] [Abstract][Full Text] [Related]
9. Nrdp1/FLRF is a ubiquitin ligase promoting ubiquitination and degradation of the epidermal growth factor receptor family member, ErbB3.
Qiu XB; Goldberg AL
Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14843-8. PubMed ID: 12411582
[TBL] [Abstract][Full Text] [Related]
10. KITENIN functions as a fine regulator of ErbB4 expression level in colorectal cancer via protection of ErbB4 from E3-ligase Nrdp1-mediated degradation.
Sun EG; Lee KH; Ko YS; Choi HJ; Yang JI; Lee JH; Chung IJ; Paek YW; Kim H; Bae JA; Kim KK
Mol Carcinog; 2017 Mar; 56(3):1068-1081. PubMed ID: 27648936
[TBL] [Abstract][Full Text] [Related]
11. Nrdp1 expression to predict clinical outcome and efficacy of adjuvant anthracyclines-based chemotherapy in breast cancer: A retrospective study.
Jiao S; Liu W; Wu M; Peng C; Tang H; Xie X
Cancer Biomark; 2015; 15(2):115-23. PubMed ID: 25519010
[TBL] [Abstract][Full Text] [Related]
12. Reticulon 4a promotes exocytosis in mammalian cells.
Mukherjee RN; Levy DL
Mol Biol Cell; 2019 Aug; 30(18):2349-2357. PubMed ID: 31318320
[TBL] [Abstract][Full Text] [Related]
13. NOGO-A/RTN4A and NOGO-B/RTN4B are simultaneously expressed in epithelial, fibroblast and neuronal cells and maintain ER morphology.
Rämö O; Kumar D; Gucciardo E; Joensuu M; Saarekas M; Vihinen H; Belevich I; Smolander OP; Qian K; Auvinen P; Jokitalo E
Sci Rep; 2016 Oct; 6():35969. PubMed ID: 27786289
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4-1 and NRDP1, in primary breast cancer.
Luhtala S; Staff S; Kallioniemi A; Tanner M; Isola J
BMC Cancer; 2018 Oct; 18(1):1045. PubMed ID: 30367623
[TBL] [Abstract][Full Text] [Related]
15. Reticulon and CLIMP-63 regulate nanodomain organization of peripheral ER tubules.
Gao G; Zhu C; Liu E; Nabi IR
PLoS Biol; 2019 Aug; 17(8):e3000355. PubMed ID: 31469817
[TBL] [Abstract][Full Text] [Related]
16. Structure-based mutagenesis of the substrate-recognition domain of Nrdp1/FLRF identifies the binding site for the receptor tyrosine kinase ErbB3.
Bouyain S; Leahy DJ
Protein Sci; 2007 Apr; 16(4):654-61. PubMed ID: 17384230
[TBL] [Abstract][Full Text] [Related]
17. Nrdp1S, short variant of Nrdp1, inhibits human glioma progression by increasing Nrdp1-mediated ErbB3 ubiquitination and degradation.
Wu Y; Wang L; Bao H; Zou S; Fu C; Gong H; Gao Y; Tang Y; Yu R; Shi H
J Cell Mol Med; 2016 Mar; 20(3):422-9. PubMed ID: 26612725
[TBL] [Abstract][Full Text] [Related]
18. Membrane Protein Quantity Control at the Endoplasmic Reticulum.
Printsev I; Curiel D; Carraway KL
J Membr Biol; 2017 Aug; 250(4):379-392. PubMed ID: 27743014
[TBL] [Abstract][Full Text] [Related]
19. The role of ErbB3 and its binding partners in breast cancer progression and resistance to hormone and tyrosine kinase directed therapies.
Hamburger AW
J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):225-33. PubMed ID: 18425425
[TBL] [Abstract][Full Text] [Related]
20. Nrdp1 inhibits growth of colorectal cancer cells by nuclear retention of p27.
Lu H; Li H; Mao D; Zhu Z; Sun H
Tumour Biol; 2014 Sep; 35(9):8639-43. PubMed ID: 24867101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
